OBJECTIVE: We tested the hypothesis that p53 frameshift mutations in ovaria
n cancer occur as a result of genomic instability rather than as a proximal
cause of this process.
STUDY DESIGN: Sequencing of the p53 tumor suppressor gene has been carried
out on 305 ovarian, fallopian tube, and peritoneal cancers. Two groups of p
53 null mutations were identified: (1) those caused by frameshift insertion
or deletion mutations (n = 31) and (2) those caused by nonsense mutations
(n = 28). As a control group 59 tumors with p53 missense mutations were sel
ected by matching with the p53 null tumors on the basis of patient age at d
iagnosis, stage and grade of cancer, cancer site, and year of diagnosis. Mi
crosatellite instability was determined from paired normal and tumor tissue
deoxyribonucleic acid by means of the following different markers: D2S123,
D5S346, D17S250, BAT25, and BAT26. Amplimers from polymerase chain reactio
ns were evaluated on 7% polyacrylamide gels.
RESULTS: The p53 null tumors were more likely to be of higher stage and gra
de. Fallopian tube cancers were more common (P =.02) in the p53 frameshift
group. The overall incidence of microsatellite instability was 39%, 36%, an
d 25% for tumors with p53 frameshift nonsense and missense mutations (P =.3
0). Microsatellite instability was seen almost exclusively with ovarian can
cer (P=.04).
CONCLUSIONS: Microsatellite instability is a relatively common event in ova
rian cancer and is dependent on marker selection. The p53 frameshift mutati
ons do not appear to occur as a consequence of genomic instability.